Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva María Moya Mateo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Geriatrics|December 9, 2025
Assessing the quality of life in patients with complex chronic conditions: Cronimad studyPilar Cubo Romano, Pilar García de la Torre, Virginia Gracia Lorenzo, et al.
European Journal of Endocrinology|July 31, 2025
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in SpainJessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2025
Mineralocorticoid receptor antagonist pre-adrenalectomy in primary aldosteronismJessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, et al.
Journal of Endocrinological Investigation|April 19, 2025
Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDOMaría Bernarda Iriarte-Durán, Miguel Paja Fano, Alicia Rizo Gellida, et al.
Journal of Hypertension|June 10, 2026
Predictors of treatment response to mineralocorticoid receptor antagonists in primary aldosteronism: insights from the SPAIN-ALDO registryJessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, et al.
Journal of Hypertension|July 25, 2024
Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registryMarta Araujo-Castro, Miguel Paja Fano, Marga González-Boillos, et al.
Endocrine Connections|July 6, 2023
Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomesMarta Araujo-Castro, Miguel Paja Fano, Begoña Pla Peris, et al.
European Journal of Endocrinology|November 18, 2024
Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort studyMarta Araujo-Castro, Miguel Paja Fano, Marga González-Boillos, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 15, 2024
Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO RegistryPaola Parra Ramírez, Patricia Martín Rojas-Marcos, Miguel Paja Fano, et al.
Frontiers in Endocrinology|March 18, 2024
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronismMarta Araujo-Castro, Paola Parra, Patricia Martín Rojas-Marcos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Geriatrics|December 9, 2025
Assessing the quality of life in patients with complex chronic conditions: Cronimad studyPilar Cubo Romano, Pilar García de la Torre, Virginia Gracia Lorenzo, et al.
European Journal of Endocrinology|July 31, 2025
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in SpainJessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2025
Mineralocorticoid receptor antagonist pre-adrenalectomy in primary aldosteronismJessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, et al.
Journal of Endocrinological Investigation|April 19, 2025
Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDOMaría Bernarda Iriarte-Durán, Miguel Paja Fano, Alicia Rizo Gellida, et al.
Journal of Hypertension|June 10, 2026
Predictors of treatment response to mineralocorticoid receptor antagonists in primary aldosteronism: insights from the SPAIN-ALDO registryJessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, et al.
Journal of Hypertension|July 25, 2024
Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registryMarta Araujo-Castro, Miguel Paja Fano, Marga González-Boillos, et al.
Endocrine Connections|July 6, 2023
Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomesMarta Araujo-Castro, Miguel Paja Fano, Begoña Pla Peris, et al.
European Journal of Endocrinology|November 18, 2024
Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort studyMarta Araujo-Castro, Miguel Paja Fano, Marga González-Boillos, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 15, 2024
Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO RegistryPaola Parra Ramírez, Patricia Martín Rojas-Marcos, Miguel Paja Fano, et al.
Frontiers in Endocrinology|March 18, 2024
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronismMarta Araujo-Castro, Paola Parra, Patricia Martín Rojas-Marcos, et al.
Pageof 2